Association study of Neuregulin-1 gene polymorphisms in a north Indian schizophrenia sample

Schizophrenia Research

Volumn 144, Issue 1-3, 2013, Pages 24-30

  Kukshal, Prachi ^a,b   Bhatia, Triptish ^c   Bhagwat, A M ^b   Gur, Raquel E ^d   Gur, Ruben C ^d   Deshpande, Smita N ^c   Nimgaonkar, Vishwajit L ^e   Thelma, B K ^a  

^a UNIVERSITY OF DELHI   (India)

^b CB Patel Research Centre   (India)

^c DR RAM MANOHAR LOHIA HOSPITAL   (India)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Association; Cognition; Haplotypes; NRG1; Schizophrenia; SNP and microsatellite markers

Indexed keywords

DNA; NEU DIFFERENTIATION FACTOR;

ADULT; ALLELE; ARTICLE; ATTENTION; BRAIN DEVELOPMENT; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; EMOTION; ETHNIC DIFFERENCE; FEMALE; GENE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; INDIA; INDIAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NEUROTRANSMISSION; NRG1 GENE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; ETHNIC GROUPS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INDIA; INFANT, NEWBORN; LINKAGE DISEQUILIBRIUM; MALE; MICROSATELLITE REPEATS; NEUREGULIN-1; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84873526335     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.12.017     Document Type: Article

References (99)

1. Addington A.M., Gornick M.C., Shaw P., Seal J., Gogtay N., Greenstein D., Clasen L., Coffey M., Gochman P., Long R., Rapoport J.L. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol. Psychiatry 2007, 12(2):195-205.
2. Backx L., Ceulemans B., Vermeesch J.R., Devriendt K., Van Esch H. Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4. Eur. J. Hum. Genet. 2009, 17(3):378-382.
3. Bao J., Wolpowitz D., Role L.W., Talmage D.A. Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 2003, 161(6):1133-1141.
4. Barch D.M., Smith E. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol. Psychiatry 2008, 64(1):11-17.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
6. Bertram L., Hiltunen M., Parkinson M., Ingelsson M., Lange C., Ramasamy K., Mullin K., Menon R., Sampson A.J., Hsiao M.Y., Elliott K.J., Velicelebi G., Moscarillo T., Hyman B.T., Wagner S.L., Becker K.D., Blacker D., Tanzi R.E. Family-based association between Alzheimer's disease and variants in UBQLN1. N. Engl. J. Med. 2005, 352(9):884-894.
7. Bhatia T., Agarwal A., Shah G., Wood J., Richard J., Gur R.E., Gur R.C., Nimgaonkar V.L., Mazumdar S., Deshpande S.N. Adjunctive cognitive remediation for schizophrenia using yoga: an open, non-randomized trial. Acta Neuropsychiatr. 2011, 24(2):91-100.
8. Bhatia T., Chakraborty S., Thomas P., Naik A., Mazumdar S., Nimgaonkar V.L., Deshpande S.N. Is familiality associated with downward occupation drift in schizophrenia?. Psychiatry Investig. 2008, 5(3):168-174.
9. Buchanan R.W., Davis M., Goff D., Green M.F., Keefe R.S., Leon A.C., Nuechterlein K.H., Laughren T., Levin R., Stover E., Fenton W., Marder S.R. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr. Bull. 2005, 31(1):5-19.
10. Cameron J.S., Dryer L., Dryer S.E. beta-Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(5):2832-2836.
11. Cannella B., Pitt D., Marchionni M., Raine C.S. Neuregulin and erbB receptor expression in normal and diseased human white matter. J. Neuroimmunol. 1999, 100(1-2):233-242.
12. Chaudhury A.R., Gerecke K.M., Wyss J.M., Morgan D.G., Gordon M.N., Carroll S.L. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2003, 62(1):42-54.
13. Chen P.L., Avramopoulos D., Lasseter V.K., McGrath J.A., Fallin M.D., Liang K.Y., Nestadt G., Feng N., Steel G., Cutting A.S., Wolyniec P., Pulver A.E., Valle D. Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am. J. Hum. Genet. 2009, 84(1):21-34.
14. Corfas G., Roy K., Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 2004, 7(6):575-580.
15. Crowley J.J., Keefe R.S., Perkins D.O., Stroup T.S., Lieberman J.A., Sullivan P.F. The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(7):1298-1300.
16. Deshpande S.N., Mathur M.N., Das S.K., Bhatia T., Sharma S., Nimgaonkar V.L. A Hindi version of the Diagnostic Interview for Genetic Studies. Schizophr. Bull. 1998, 24(3):489-493.
17. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008, 66(2):87-98.
18. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003, 25(2):115-121.
19. Falls D.L. Neuregulins and the neuromuscular system: 10years of answers and questions. J. Neurocytol. 2003, 32(5-8):619-647.
20. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 2003, 284(1):14-30.
21. Faraone S.V., Taylor L., Tsuang M.T. The molecular genetics of schizophrenia: an emerging consensus. Expert Rev. Mol. Med. 2002, 4(14):1-13.
22. Farrer M., Chan P., Chen R., Tan L., Lincoln S., Hernandez D., Forno L., Gwinn-Hardy K., Petrucelli L., Hussey J., Singleton A., Tanner C., Hardy J., Langston J.W. Lewy bodies and Parkinsonism in families with parkin mutations. Ann. Neurol. 2001, 50(3):293-300.
23. Fischbach G.D., Rosen K.M. ARIA: a neuromuscular junction neuregulin. Annu. Rev. Neurosci. 1997, 20:429-458.
24. Garcia-Barcelo M.M., Tang C.S., Ngan E.S., Lui V.C., Chen Y., So M.T., Leon T.Y., Miao X.P., Shum C.K., Liu F.Q., Yeung M.Y., Yuan Z.W., Guo W.H., Liu L., Sun X.B., Huang L.M., Tou J.F., Song Y.Q., Chan D., Cheung K.M., Wong K.K., Cherny S.S., Sham P.C., Tam P.K. Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(8):2694-2699.
25. Gardner M., González-Neira A., Lao O., Calafell F., Bertranpetit J., Comas D. Extreme population differences across Neuregulin 1 gene, with implications forassociation studies. Mol. Psychiatry 2006, 11(1):66-75.
26. Gauderman W.J., Morrison J.M. QUANTO 1.1: A Computer Program for Power and Sample Size Calculations for Genetic-epidemiology Studies 2006, (http://hydra.usc.edu/gxe).
27. Gerlai R., Pisacane P., Erickson S. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav. Brain Res. 2000, 109(2):219-227.
28. Go R.C., Perry R.T., Wiener H., Bassett S.S., Blacker D., Devlin B., Sweet R.A. Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 139B(1):28-32.
29. Goes F.S., Sanders L.L., Potash J.B. The genetics of psychotic bipolar disorder. Curr. Psychiatry Rep. 2008, 10(2):178-189.
30. Goldberg T.E., Green M.F. Neurocognitive functioning in patients with schizophrenia: an overview. Neuropsychopharmacology: The Fifth Generation of Progress 2002, Lippincott Williams & Wilkins. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
31. Gong Y.G., Wu C.N., Xing Q.H., Zhao X.Z., Zhu J., He L. A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia. Schizophr. Res. 2009, 111(1-3):109-114.
32. Greenwood T.A., Light G.A., Swerdlow N.R., Radant A.D., Braff D.L. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS One 2012, 7(1):e29630.
33. Gu Z., Jiang Q., Fu A.K., Ip N.Y., Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 2005, 25(20):4974-4984.
34. Gur R.C., Ragland J.D., Moberg P.J., Bilker W.B., Kohler C., Siegel S.J., Gur R.E. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology 2001, 25(5):777-788.
35. Gur R.E., Nimgaonkar V.L., Almasy L., Calkins M.E., Ragland J.D., Pogue-Geile M.F., Kanes S., Blangero J., Gur R.C. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am. J. Psychiatry 2007, 164(5):813-819.
36. Hall J., Whalley H.C., Job D.E., Baig B.J., McIntosh A.M., Evans K.L., Thomson P.A., Porteous D.J., Cunningham-Owens D.G., Johnstone E.C., Lawrie S.M. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 2006, 9(12):1477-1478.
37. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 2006, 60(2):132-140.
38. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005, 10(1):40-68. (image 45).
39. Hashimoto R., Straub R.E., Weickert C.S., Hyde T.M., Kleinman J.E., Weinberger D.R. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004, 9(3):299-307.
40. Heinrichs R.W., Ruttan L., Zakzanis K.K., Case D. Parsing schizophrenia with neurocognitive tests: evidence of stability and validity. Brain Cogn. 1997, 35(2):207-224.
41. Hong L.E., Wonodi I., Lewis J., Thaker G.K. Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. Neuropsychopharmacology 2008, 33(9):2167-2174.
42. Keri S., Kelemen O. An objective method for the assessment of expressed emotions and symptoms during direct family transactions in schizophrenia. Neuropsychopharmacol. Hung. 2008, 10(1):5-8.
43. Kircher T., Thienel R., Wagner M., Reske M., Habel U., Kellermann T., Frommann I., Schwab S., Wolwer W., von Wilmsdorf M., Braus D.F., Schmitt A., Rapp A., Stocker T., Shah N.J., Henn F.A., Sauer H., Gaebel W., Maier W., Schneider F. Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259(2):72-79.
44. Kircher T., Krug A., Markov V., Whitney C., Krach S., Zerres K., Eggermann T., Stocker T., Shah N.J., Treutlein J., Nothen M.M., Becker T., Rietschel M. Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals. Hum. Brain Mapp. 2009, 30(10):3406-3416.
45. Konrad A., Winterer G. Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?. Schizophr. Bull. 2008, 34(1):72-92.
46. Krug A., Markov V., Eggermann T., Krach S., Zerres K., Stocker T., Shah N.J., Schneider F., Nothen M.M., Treutlein J., Rietschel M., Kircher T. Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with differences in frontal brain activation in a working memory task in healthy individuals. NeuroImage 2008, 42(4):1569-1576.
47. Krug A., Markov V., Krach S., Jansen A., Zerres K., Eggermann T., Stocker T., Shah N.J., Nothen M.M., Treutlein J., Rietschel M., Kircher T. The effect of Neuregulin 1 on neural correlates of episodic memory encoding and retrieval. NeuroImage 2010, 53(3):985-991.
48. Kurnianingsih Y.A., Kuswanto C.N., McIntyre R.S., Qiu A., Ho B.C., Sim K. Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J. Neural Transm. 2011, 118(11):1621-1639.
49. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., Harrison P.J., Kleinman J.E., Weinberger D.R. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(17):6747-6752.
50. Li D., Collier D.A., He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum. Mol. Genet. 2006, 15(12):1995-2002.
51. Lipska B.K. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J. Psychiatry Neurosci. 2004, 29(4):282-286.
52. Liu X., Bates R., Yin D.M., Shen C., Wang F., Su N., Kirov S.A., Luo Y., Wang J.Z., Xiong W.C., Mei L. Specific regulation of NRG1 isoform expression by neuronal activity. J. Neurosci. 2011, 31(23):8491-8501.
53. Mata I., Perez-Iglesias R., Roiz-Santianez R., Tordesillas-Gutierrez D., Gonzalez-Mandly A., Berja A., Vazquez-Barquero J.L., Crespo-Facorro B. Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. NeuroImage 2010, 53(3):1016-1022.
54. Mata I., Perez-Iglesias R., Roiz-Santianez R., Tordesillas-Gutierrez D., Gonzalez-Mandly A., Vazquez-Barquero J.L., Crespo-Facorro B. A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biol. Psychiatry 2009, 65(6):535-540.
55. McClay J.L., Adkins D.E., Aberg K., Bukszar J., Khachane A.N., Keefe R.S., Perkins D.O., McEvoy J.P., Stroup T.S., Vann R.E., Beardsley P.M., Lieberman J.A., Sullivan P.F., van den Oord E.J. Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. Neuropsychopharmacology 2010, 36(3):616-626.
56. McIntosh A.M., Moorhead T.W., Job D., Lymer G.K., Munoz Maniega S., McKirdy J., Sussmann J.E., Baig B.J., Bastin M.E., Porteous D., Evans K.L., Johnstone E.C., Lawrie S.M., Hall J. The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry 2008, 13(11):1054-1059.
57. Moon E., Rollins B., Mesen A., Sequeira A., Myers R.M., Akil H., Watson S.J., Barchas J., Jones E.G., Schatzberg A., Bunney W.E., DeLisi L.E., Byerley W., Vawter M.P. Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Schizophr. Res. 2011, 131(1-3):52-57.
58. Munafo M.R., Attwood A.S., Flint J. Neuregulin 1 genotype and schizophrenia. Schizophr. Bull. 2008, 34(1):9-12.
59. Munafo M.R., Thiselton D.L., Clark T.G., Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 2006, 11(6):539-546.
60. Naz M., Riaz M., Saleem M. Potential role of Neuregulin 1 and TNF-alpha (-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan. Mol. Biol. Rep. 2011, 38(7):4709-4714.
61. Ng M.Y., Levinson D.F., Faraone S.V., Suarez B.K., DeLisi L.E., Arinami T., Riley B., Paunio T., Pulver A.E., Irmansyah, Holmans P.A., Escamilla M., Wildenauer D.B., Williams N.M., Laurent C., Mowry B.J., Brzustowicz L.M., Maziade M., Sklar P., Garver D.L., Abecasis G.R., Lerer B., Fallin M.D., Gurling H.M., Gejman P.V., Lindholm E., Moises H.W., Byerley W., Wijsman E.M., Forabosco P., Tsuang M.T., Hwu H.G., Okazaki Y., Kendler K.S., Wormley B., Fanous A., Walsh D., O'Neill F.A., Peltonen L., Nestadt G., Lasseter V.K., Liang K.Y., Papadimitriou G.M., Dikeos D.G., Schwab S.G., Owen M.J., O'Donovan M.C., Norton N., Hare E., Raventos H., Nicolini H., Albus M., Maier W., Nimgaonkar V.L., Terenius L., Mallet J., Jay M., Godard S., Nertney D., Alexander M., Crowe R.R., Silverman J.M., Bassett A.S., Roy M.A., Merette C., Pato C.N., Pato M.T., Roos J.L., Kohn Y., Amann-Zalcenstein D., Kalsi G., McQuillin A., Curtis D., Brynjolfson J., Sigmundsson T., Petursson H., Sanders A.R., Duan J., Jazin E., Myles-Worsley M., Karayiorgou M., Lewis C.M. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 2009, 14(8):774-785.
62. Nicodemus K.K., Law A.J., Radulescu E., Luna A., Kolachana B., Vakkalanka R., Rujescu D., Giegling I., Straub R.E., McGee K., Gold B., Dean M., Muglia P., Callicott J.H., Tan H.Y., Weinberger D.R. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch Gen Psychiatry 2010, 67(10):991-1001.
63. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies.Rationale, unique features, and training.NIMH Genetics Initiative. Arch. Gen. Psychiatry 1994, 51(11):849-859. (discussion 863-844).
64. O'Tuathaigh C.M., Babovic D., O'Sullivan G.J., Clifford J.J., Tighe O., Croke D.T., Harvey R., Waddington J.L. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 2007, 147(1):18-27.
65. Ozaki M., Sasner M., Yano R., Lu H.S., Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 1997, 390(6661):691-694.
66. Potkin S.G., Turner J.A., Guffanti G., Lakatos A., Torri F., Keator D.B., Macciardi F. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn. Neuropsychiatry 2009, 14(4-5):391-418.
67. Prata D.P., Breen G., Osborne S., Munro J., St Clair D., Collier D.A. An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis. Psychiatr. Genet. 2009, 19(3):113-116.
68. Raj E.H., Skinner A., Mahji U., Nirmala K.N., Ravichandran K., Shanta V., Hurst H.C., Gullick W.J., Rajkumar T. Neuregulin 1-alpha expression in locally advanced breast cancer. Breast 2001, 10(1):41-45.
69. Ranganath C., Minzenberg M.J., Ragland J.D. The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol. Psychiatry 2008, 64(1):18-25.
70. Reichenberg A., Harvey P.D. Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol. Bull. 2007, 133(5):833-858.
71. Rieff H.I., Raetzman L.T., Sapp D.W., Yeh H.H., Siegel R.E., Corfas G. Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J. Neurosci. 1999, 19(24):10757-10766.
72. Rimer M., Barrett D.W., Maldonado M.A., Vock V.M., Gonzalez-Lima F. Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 2005, 16(3):271-275.
73. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., Clair St, Corvin D., Gurling A., Werge H., Rujescu T., Blackwood D., Pato D.H., Malhotra C.N., Purcell A.K., Dudbridge S., Neale F., Rossin B.M., Visscher L., Posthuma P.M., Ruderfer D., Fanous D.M., Stefansson A., Steinberg H., Mowry S., Golimbet B.J., De Hert V., Jonsson M., Bitter E.G., Pietilainen I., Collier O.P., Tosato D.A., Agartz S., Albus I., Alexander M., Amdur M., Amin R.L., Bass F., Bergen N., Black S.E., Borglum D.W., Brown A.D., Bruggeman M.A., Buccola R., Byerley N.G., Cahn W.F., Cantor W., Carr R.M., Catts V.J., Choudhury S.V., Cloninger K., Cormican C.R., Craddock P., Danoy N., Datta P.A., de Haan S., Demontis L., Dikeos D., Djurovic D., Donnelly S., Donohoe P., Duong G., Dwyer L., Fink-Jensen S., Freedman A., Freimer R., Friedl N.B., Georgieva M., Giegling L., Gill I., Glenthoj M., Godard B., Hamshere S., Hansen M., Hansen M., Hartmann T., Henskens A.M., Hougaard F.A., Hultman D.M., Ingason C.M., Jablensky A., Jakobsen A.V., Jay K.D., Jurgens M., Kahn G., Keller R.S., Kenis M.C., Kenny G., Kim E., Kirov Y., Konnerth G.K., Konte H., Krabbendam B., Krasucki L., Lasseter R., Laurent V.K., Lawrence C., Lencz J., Lerer T., Liang F.B., Lichtenstein K.Y., Lieberman P., Linszen J.A., Lonnqvist D.H., Loughland J., Maclean C.M., Maher A.W., Maier B.S., Mallet W., Malloy J., Mattheisen P., Mattingsdal M., McGhee M., McGrath K.A., McIntosh J.J., McLean A., McQuillin D.E., Melle A., Michie I., Milanova P.T., Morris V., Mors D.W., Mortensen O., Moskvina P.B., Muglia V., Myin-Germeys P., Nertney I., Nestadt D.A., Nielsen G., Nikolov J., Nordentoft I., Norton M., Nothen N., O'Dushlaine M.M., Olincy C.T., Olsen A., O'Neill L., Orntoft F.A., Owen T.F., Pantelis M.J., Papadimitriou C., Pato G., Peltonen M.T., Petursson L., Pickard H., Pimm B., Pulver J., Puri A.E., Quested V., Quinn D., Rasmussen E.M., Rethelyi H.B., Ribble J.M., Rietschel R., Riley M., Ruggeri B.P., Schall M., Schulze U., Schwab T.G., Scott S.G., Shi R.J., Sigurdsson J., Silverman E., Spencer J.M., Stefansson C.C., Strange K., Strengman A., Stroup E., Suvisaari T.S., Terenius J., Thirumalai L., Thygesen S., Timm J.H., Toncheva S., van den Oord D., van Os E., van Winkel J., Veldink R., Walsh J., Wang D., Wiersma A.G., Wildenauer D., Williams D.B., Williams H.J., Wormley N.M., Zammit B., Sullivan S., O'Donovan P.F., Daly M.C., Gejman M.J., P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
74. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2(5):e141.
75. Schmechtig A., Vassos E., Kumari V., Hutton S.B., Collier D.A., Morris R.G., Williams S.C., Ettinger U. Association of Neuregulin 1 rs3924999 genotype with antisaccades and smooth pursuit eye movements. Genes Brain Behav. 2010, 9(6):621-627.
76. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 1995, 59(Pt 1):97-105.
77. Shamir A., Buonanno A. Molecular and cellular characterization of Neuregulin-1 type IV isoforms. J. Neurochem. 2010, 113(5):1163-1176.
78. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
79. Shi Y., Li Z., Xu Q., Wang T., Li T., Shen J., Zhang F., Chen J., Zhou G., Ji W., Li B., Xu Y., Liu D., Wang P., Yang P., Liu B., Sun W., Wan C., Qin S., He G., Steinberg S., Cichon S., Werge T., Sigurdsson E., Tosato S., Palotie A., Nothen M.M., Rietschel M., Ophoff R.A., Collier D.A., Rujescu D., Clair D.S., Stefansson H., Stefansson K., Ji J., Wang Q., Li W., Zheng L., Zhang H., Feng G., He L. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat. Genet. 2011, 43(12):1224-1227.
80. Shirts B.H., Nimgaonkar V. The genes for schizophrenia: finally a breakthrough?. Curr. Psychiatry Rep. 2004, 6(4):303-312.
81. Shyu W.C., Lin S.Z., Chiang M.F., Yang H.I., Thajeb P., Li H. Neuregulin-1 reduces ischemia-induced brain damage in rats. Neurobiol. Aging 2004, 25(7):935-944.
82. Snitz B.E., Macdonald A.W., Carter C.S. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr. Bull. 2006, 32(1):179-194.
83. Sprooten E., Lymer G.K., Munoz Maniega S., McKirdy J., Clayden J.D., Bastin M.E., Porteous D., Johnstone E.C., Lawrie S.M., Hall J., McIntosh A.M. The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants. Mol Psychiatry 2009, 14(3):237-238. (233).
84. Stefanis N.C., Trikalinos T.A., Avramopoulos D., Smyrnis N., Evdokimidis I., Ntzani E.E., Ioannidis J.P., Stefanis C.N. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol. Psychiatry 2007, 62(7):784-792.
85. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., Gunnarsdottir S., Walker N., Petursson H., Crombie C., Ingason A., Gulcher J.R., Stefansson K., St Clair D. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 2003, 72(1):83-87.
86. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G., Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S., Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V., Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H., Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71(4):877-892.
87. Steinthorsdottir V., Stefansson H., Ghosh S., Birgisdottir B., Bjornsdottir S., Fasquel A.C., Olafsson O., Stefansson K., Gulcher J.R. Multiple novel transcription initiation sites for NRG1. Gene 2004, 342(1):97-105.
88. Talkowski M.E., Bamne M., Mansour H., Nimgaonkar V.L. Dopamine genes and schizophrenia: case closed or evidence pending?. Schizophr. Bull. 2007, 33(5):1071-1081.
89. Talkowski M.E., McCann K.L., Chen M., McClain L., Bamne M., Wood J., Chowdari K.V., Watson A., Prasad K.M., Kirov G., Georgieva L., Toncheva D., Mansour H., Lewis D.A., Owen M., O'Donovan M., Papasaikas P., Sullivan P., Ruderfer D., Yao J.K., Leonard S., Thomas P., Miyajima F., Quinn J., Lopez A.J., Nimgaonkar V.L. Fine-mapping reveals novel alternative splicing of the dopamine transporter. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(8):1434-1447.
90. Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R., Law A.J. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J. Biol. Chem. 2007, 282(33):24343-24351.
91. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res. 2009, 110(1-3):1-23.
92. Tang B., Thornton-Wells T., Askland K.D. Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia. PLoS One 2011, 6(4):e19073.
93. Thomson P.A., Christoforou A., Morris S.W., Adie E., Pickard B.S., Porteous D.J., Muir W.J., Blackwood D.H., Evans K.L. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 2007, 12(1):94-104.
94. Viehover A., Miller R.H., Park S.K., Fischbach G., Vartanian T. Neuregulin: an oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev. Neurosci. 2001, 23(4-5):377-386.
95. Walker R.M., Christoforou A., Thomson P.A., McGhee K.A., Maclean A., Muhleisen T.W., Strohmaier J., Nieratschker V., Nothen M.M., Rietschel M., Cichon S., Morris S.W., Jilani O., Stclair D., Blackwood D.H., Muir W.J., Porteous D.J., Evans K.L. Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder. Neurosci. Lett. 2010, 478(1):9-13.
96. Wang F., Jiang T., Sun Z., Teng S.L., Luo X., Zhu Z., Zang Y., Zhang H., Yue W., Qu M., Lu T., Hong N., Huang H., Blumberg H.P., Zhang D. Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. J. Psychiatry Neurosci. 2009, 34(3):181-186.
97. Walss-Bass C., Liu W., Lew D.F., Villegas R., Montero P., Dassori A., Leach R.J., Almasy L., Escamilla M., Raventos H. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry 2006, 60(6):548-553.
98. Xu Z., Jiang J., Ford G., Ford B.D. Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke. Biochem. Biophys. Res. Commun. 2004, 322(2):440-446.
99. Yokley J.L., Prasad K.M., Chowdari K.V., Talkowski M.E., Wood J., Gur R.C., Gur R.E., Almasy L., Nimgaonkar V.L., Pogue-Geile M.F. Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families. Psychiatr. Genet. 2012, 22(2):70-81.